SCHEMBL420549

SCHEMBL420549

CCCCCCCCCC(=O)NC(CCC)(C(=O)[O-])[N+](C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
HSP90AA1 P07900 1/20 0.43
CPT2 P23786 1/20 0.43
CPT1A P50416 1/20 0.43
CPT1B Q92523 1/20 0.43
FAAH O00519 4/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
GRK2 P25098 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CES2 O00748 3/20 0.40
CES1 P23141 3/20 0.40
MAPK1 P28482 1/20 0.40
FABP3 P05413 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309808 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL3720030 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL459434 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL139532 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL43085 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL418327 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL458992 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL1311278 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL1310843 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL1309574 0.98 ALDH1A1 (0.49) ALDH1A1HRH3HSP90AA1CPT2CPT1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3472285-A1 C8-10-ALKYLAMIDOALKYL BEATAINE AS ANTI-WRINKLE AGENT Henkel AG & Co. KGaA (DE) 2019-04-24 EP claimed
WO-2017129310-A1 C8-10-ALKYLAMIDOALKYL BETAINE AS ANTI-WRINKLE AGENT HENKEL AG & CO. KGAA (DE) 2017-08-03 WO claimed
EP-3107986-A1 WASHING OR CLEANING COMPOSITION HAVING IMPROVED FOAMING CHARACTERISTICS WITH A HIGH LEVEL OF SOILING Henkel AG & Co. KGaA (DE) 2016-12-28 EP claimed
WO-2015124189-A1 WASHING OR CLEANING COMPOSITION HAVING IMPROVED FOAMING CHARACTERISTICS WITH A HIGH LEVEL OF SOILING HENKEL AG & CO. KGAA (DE) 2015-08-27 WO claimed
US-8722588-B2 Foaming composition for high temperature and salinity INSTITUTO MEXICANO DEL PETROLEO (MX) 2014-05-13 US claimed
US-20110275546-A1 FOAMING COMPOSITION FOR HIGH TEMPERATURE AND SALINITY INSTITUTO MEXICANO DEL PETROLEO (MX) 2011-11-10 US claimed
EP-2374530-A1 FOAMING COMPOSITION FOR HIGH TEMPERATURE AND SALINITY Instituto Mexicano Del Petróleo (MX) 2011-10-12 EP claimed
EP-1391193-B1 Silicone-in-water emulsion comprising specific polyether-polydimethylsiloxane copolymer BEIERSDORF AG (DE) 2007-01-03 EP claimed
US-12025483-B2 Test method development for mass flow identification of occluding small particulates in microlumens Innovative Health (US) 2024-07-02 US disclosed
EP-3977062-B1 TEST METHOD DEVELOPMENT FOR MASS FLOW IDENTIFICATION OF OCCLUDING SMALL PARTICULATES IN MICROLUMENS Innovative Health (US) 2024-04-03 EP disclosed
CN-117618269-A Sulfate-free shampoo 威娜德国有限责任公司 2024-03-01 CN disclosed
EP-4282944-A1 UNIT DOSE FOR PERSONAL CARE OR HOUSEHOLD CARE COMPOSITION Dalli-Werke GmbH & Co. KG (DE) 2023-11-29 EP disclosed
US-11771082-B2 Disinfecting composition GOJO INDUSTRIES, INC. (US) 2023-10-03 US disclosed
EP-4229169-A1 LAUNDRY DETERGENT PORTION UNIT Henkel AG & Co. KGaA (DE) 2023-08-23 EP disclosed
EP-1400579-A2 Composition with anti-oxidative properties MERCK PATENT GmbH (DE) 2004-03-24 EP disclosed
EP-1382329-A1 Compositions for photoprotection comprising a flavonoid MERCK PATENT GmbH (DE) 2004-01-21 EP disclosed
US-20030060426-A1 Formulation for protection against oxidative stress containing benzofuranone derivatives MERCK PATENT GMBH (DE) 2003-03-27 US disclosed
EP-1250331-A1 FORMULATION FOR PROTECTION AGAINST OXIDATIVE STRESS CONTAINING BENZOFURANONE DERIVATIVES MERCK PATENT GmbH (DE) 2002-10-23 EP disclosed
WO-2001055128-A1 FORMULATION FOR PROTECTION AGAINST OXIDATIVE STRESS CONTAINING BENZOFURANONE DERIVATIVES MERCK PATENT GMBH (DE) 2001-08-02 WO disclosed
EP-0908172-A1 Cosmetic and dermatological photoprotective compositions in the form of O/W emulsions containing hydrophobic inorganic micropigments and hydrophilic surfactants Beiersdorf Aktiengesellschaft (DE) 1999-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060426-A1 Formulation for protection against oxidative stress containing benzofuranone derivatives NQO1, NFE2L2, GPX4 ALDH1A1 87/4885HRH3 4074/4885HSP90AA1 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.